Related Experiment Video
Updated: Jun 1, 2026
09:43
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Refractory disease in systemic lupus erythematosus.
Ana Campar1, Fátima Farinha, Carlos Vasconcelos
1Santo António Hospital, Internal Medicine Department, Porto, Portugal. anaccampar@hotmail.com
Autoimmunity Reviews
|May 24, 2011
Summary
Systemic Lupus Erythematosus (SLE) lacks clear definitions for refractory disease (RD). This review explores RD concepts, management, and therapies for specific SLE involvements, highlighting the need for better diagnostics and targeted treatments.
Area of Science:
- Rheumatology
- Immunology
- Clinical Medicine
Background:
- Systemic Lupus Erythematosus (SLE) lacks a standardized definition and guidelines for refractory disease (RD).
- New therapeutic agents are primarily investigated in patients with refractory SLE.
- The concept of RD in SLE is complex, requiring deeper insights into disease pathogenesis and patient heterogeneity.
Purpose of the Study:
- To analyze key concepts for a global definition of RD in SLE, excluding lupus nephritis.
- To discuss management strategies and review therapeutic options for specific SLE manifestations.
- To address the need for improved monitoring and definition of RD in SLE.
Main Methods:
- Literature review and conceptual analysis of refractory disease in Systemic Lupus Erythematosus.
- Examination of diagnostic challenges, including patient compliance and accurate SLE attribution.
- Analysis of therapeutic approaches for cutaneous, articular, hematological, and neuropsychiatric lupus.
Main Results:
- Accurate diagnosis and patient compliance are critical for identifying true refractory SLE.
- Current RD management relies heavily on clinical experience due to limited randomized trials.
- Heterogeneity of SLE necessitates consideration of single-organ indications for drug approval.
Conclusions:
- A precise definition and validated activity indices are crucial for monitoring RD in SLE.
- Development of better biomarkers and prospective studies are needed to advance the understanding and treatment of refractory SLE.
- Targeted therapies and improved diagnostic accuracy are essential for managing refractory SLE patients.
Related Concept Videos
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...